GUERRA, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 9.864
AS - Asia 5.714
EU - Europa 4.405
SA - Sud America 841
AF - Africa 119
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 6
Totale 20.961
Nazione #
US - Stati Uniti d'America 9.421
SG - Singapore 1.806
VN - Vietnam 1.418
IT - Italia 1.198
CN - Cina 1.081
BR - Brasile 644
DE - Germania 641
HK - Hong Kong 604
RU - Federazione Russa 593
SE - Svezia 469
CA - Canada 356
IE - Irlanda 349
GB - Regno Unito 254
UA - Ucraina 204
FR - Francia 191
IN - India 170
BD - Bangladesh 123
FI - Finlandia 90
AT - Austria 84
AR - Argentina 66
IQ - Iraq 62
TR - Turchia 60
DK - Danimarca 59
ES - Italia 59
JP - Giappone 53
KR - Corea 50
MX - Messico 50
PK - Pakistan 46
NL - Olanda 44
PL - Polonia 43
ID - Indonesia 42
EC - Ecuador 37
ZA - Sudafrica 34
SA - Arabia Saudita 31
VE - Venezuela 30
BE - Belgio 28
PH - Filippine 27
KE - Kenya 20
CZ - Repubblica Ceca 19
CO - Colombia 18
UZ - Uzbekistan 18
BG - Bulgaria 17
JO - Giordania 17
CH - Svizzera 15
CL - Cile 14
MA - Marocco 12
MY - Malesia 12
RO - Romania 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
PY - Paraguay 10
TH - Thailandia 10
UY - Uruguay 10
OM - Oman 9
EG - Egitto 8
IR - Iran 8
PT - Portogallo 8
AZ - Azerbaigian 7
DZ - Algeria 7
PE - Perù 7
AU - Australia 6
DO - Repubblica Dominicana 6
IL - Israele 6
JM - Giamaica 6
KG - Kirghizistan 6
LT - Lituania 6
AL - Albania 5
BO - Bolivia 5
EU - Europa 5
NI - Nicaragua 5
PS - Palestinian Territory 5
AO - Angola 4
CR - Costa Rica 4
HN - Honduras 4
KZ - Kazakistan 4
NG - Nigeria 4
NP - Nepal 4
XK - ???statistics.table.value.countryCode.XK??? 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CY - Cipro 3
ET - Etiopia 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
LB - Libano 3
LK - Sri Lanka 3
MK - Macedonia 3
MM - Myanmar 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
MD - Moldavia 2
PA - Panama 2
PR - Porto Rico 2
RS - Serbia 2
SC - Seychelles 2
SO - Somalia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
Totale 20.938
Città #
Ann Arbor 1.819
Singapore 1.145
Ashburn 887
Hong Kong 584
San Jose 582
Fairfield 557
Woodbridge 461
Ho Chi Minh City 446
Chandler 444
Houston 408
Wilmington 397
Milan 364
Dublin 336
Frankfurt am Main 332
Hanoi 320
Dearborn 248
New York 244
Seattle 237
Toronto 202
Jacksonville 199
Santa Clara 187
Los Angeles 181
Cambridge 177
Beijing 173
The Dalles 160
Princeton 134
Chicago 130
Dallas 127
Lissone 104
Shanghai 104
Hefei 89
Nanjing 77
Lauterbourg 75
São Paulo 66
Vienna 65
Lawrence 61
Da Nang 58
Altamura 52
Buffalo 50
Moscow 50
Munich 49
Council Bluffs 48
Guangzhou 48
London 46
San Diego 44
Seoul 44
Falls Church 43
Tokyo 42
Helsinki 40
Fremont 38
Haiphong 38
Montreal 34
Orem 33
Lachine 30
Boardman 29
Shenyang 29
Warsaw 29
Jinan 28
Biên Hòa 27
Hải Dương 27
Jakarta 27
Nanchang 27
Poplar 27
Dong Ket 26
Chennai 25
Nuremberg 24
Brussels 23
Bắc Ninh 23
Thái Nguyên 23
Monza 22
Brooklyn 21
Ha Long 21
Ottawa 21
Atlanta 20
Manchester 20
Vancouver 20
Baghdad 19
Dhaka 19
Johannesburg 19
Ninh Bình 19
Stockholm 19
Vũng Tàu 19
Andover 18
Rome 18
Tashkent 18
Hebei 17
Boston 16
Lahore 16
Nairobi 16
Rio de Janeiro 16
Salt Lake City 16
Segrate 16
Amman 15
Amsterdam 15
Bắc Giang 15
Genoa 15
Kunming 15
Paris 15
Brno 14
Columbus 14
Totale 13.847
Nome #
Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms 726
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol 529
18F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor? 485
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 473
18F-FDG PET/CT in a Case of Metastatic Breast Cancer to the Vulva 450
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 442
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 436
Cardiotoxicity in breast cancer patients: the role of gated myocardial perfusion SPECT 412
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study 407
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 388
18F-FDG PET/CT in preoperative staging of vulvar cancer patients: Is it really effective? 364
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 359
Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer 99mTc and/or Blue Dye 356
Comparative evaluation of CT-based and respiratory-gated PET/CT-based planning target volume (PTV) in the definition of radiation treatment planning in lung cancer: preliminary results 353
Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye 348
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 347
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 345
Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer 345
Motion management in PET/CT: Technological solutions 344
Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT 344
Respiratory motion management in PET/CT: applications and clinical usefulness 342
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 326
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 326
Prevalence of interstitial pneumonia suggestive of COVID-19 at 18F-FDG PET/CT in oncological asymptomatic patients in a high prevalence country during pandemic period: a national multi-centric retrospective study 312
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 312
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 309
Erratum: ☆Corrigendum to “Recommendations for surveillance and follow-up of men with testicular germ cell tumors: A multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica” (Critical Reviews in Oncology / Hematology (2019) 137 (154–164), (S1040842819300587), (10.1016/j.critrevonc.2019.03.006)) 309
Lungs of patients with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions: A [18F]-fluoro-2-deoxy-D-glucose PET/CT study 308
Validity of cingulate–precuneus–temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer’s Disease 304
Inflammatory activation during coronary artery surgery and its dose-dependent modulation by statin/ACE-inhibitor combination 300
Intracavitary Brachytherapy in Cervical Carcinoma: The Role of F18-FDGPET in Treatment Planning 298
The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism 296
Combined value of apparent diffusion coefficient-standardized uptake value max in evaluation of post-treated locally advanced rectal cancer 293
Recommendations for surveillance and follow-up of men with testicular germ cell tumors: a multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica 292
Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (Nsclc): A real world experience 289
Feasibility of perfusion CT technique integrated into conventional 18FDG/PET-CT studies in lung cancer patients: clinical staging and functional information in a single study 282
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 280
Radiolabeled fibroblast activation protein inhibitor (FAPI) PET in oncology: has the time come for 18F-fluorodeoxyglucose to think to a well-deserved retirement? 280
Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patients 278
Lung Regional Metabolic Activity and Gas Volume Changes Induced by Tidal Ventilation in Patients with Acute Lung Injury 273
Italian Multicenter Study on Accuracy of 18 F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma 267
Performance measurements for the PET/CT Discovery-600 using NEMA NU 2-2007 standards 255
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 249
A case of Melas (A3243G) on chronic dichloroacetate treatment 247
Maximum standardized uptake value (SUVmax) as prognostic factor for surgical cytoreduction and response to adjuvant chemotherapy in women submitted to 18F-FDG PET/CT for staging of advanced epithelial ovarian cancer (aEOC) 247
Imaging of lung inflammation during severe influenza A: H1N1 241
Contained rupture of common iliac artery aneurysm in a contrast-enhanced PET/CT study 240
Focal bone lesions in hiv-positive patient treated with tenofovir 239
Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye 237
Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: Detection of pelvic nodal metastases 229
Respiratory gated PET/CT in a European multicentre retrospective study: added diagnostic value in detection and characterization of lung lesions 229
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study 227
PET/CT and contrast enhanced CT in single vs. two separate sessions: a cost analysis study 226
Tidal changes on CT and progression of ARDS 225
Assessment of nodal status by 18F-FDG PET/CT in early stage ovarian cancer 224
FDG PET in response evaluation of bulky masses in paediatric Hodgkin’s lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial 218
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial 212
Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? 205
End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial 191
The need of a clinically oriented reporting of 18F-FDG PET/CT in non-small cell lung cancer (NSCLC) 190
Comment on 'Pre-operative nomogram for the identification of lymph node metastasis in early cervical cancer' 189
International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline 18F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation 187
Performance of a SPECT collimator-detector response reconstruction algorithm: phantom studies and validation in inflammation clinical studies 183
Postchemotherapy PET evaluation correlates with patient outcome in paediatric Hodgkin's disease 171
Respiratory Gating and the performance of PET/CT in pulmonary lesions 171
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial 163
The 68Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma) 148
Risk-related 18F-FDG PET/CT and new diagnostic strategies in patients with solitary pulmonary nodule: the ITALIAN multicenter trial 139
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi 137
Hairy cell leukemia with an atypical extranodal presentation: A clinicopathological analysis of four cases 136
Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial 134
Is there a role for metabolic imaging in pediatric non-Hodgkin lymphoma? 119
Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 Trial 117
Prognostic value of PET-CT after fi rst-line therapy in patients with follicular lymphoma: A pooled analysis of central scan review in three multicentre studies 116
Immunoscintigraphy of ovarian cancer recurrences: comparison with surgical findings and CT scan or US results 110
Predictive value of pre-treatment FDG PET in patients with non-Hodgkin lymphoma treated with radioimmunotherapy: a systematic review 105
Current status of FDG-PET/CT in staging of adult lymphoma 100
Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT 89
Diagnostic Reference Levels in nuclear medicine for Positron Emission Tomography examinations: First Italian multicenter data collection 62
Advanced stage classical Hodgkin lymphoma patients with a positive interim-PET (PET-2) Deauville score 5 after 2 ABVD cycles: a pooled analysis of three multicenter trials 35
Pitfalls and artifacts in [18F]-FDG PET imaging in children with lymphoma 27
Totale 21.498
Categoria #
all - tutte 63.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.935


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021345 0 0 0 0 0 0 0 0 0 0 150 195
2021/20221.250 140 159 142 109 69 81 68 57 54 117 98 156
2022/20231.791 180 513 168 199 100 276 9 112 121 52 42 19
2023/20241.211 38 40 58 59 140 309 253 56 77 20 13 148
2024/20252.834 145 338 207 119 196 150 195 111 235 462 248 428
2025/20268.197 1.480 548 617 880 952 407 1.264 374 634 661 380 0
Totale 21.498